Use of Acthar in Patients With FSGS That Will be Undergoing Renal Transplantation

Completed · Phase 3

Conditions studied: FSGS

In brief

This study will evaluate the use of Acthar in patients to undergo renal transplantation and will measure the rate of FSGS recurrence.

Key facts

Study ID

NCT02683889

Run by

University of Colorado, Denver

People needed

15

Starts

2019-02-01

Expected to finish

2024-06-10

Last updated by the study team

2026-07-01

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• FSGS
• To receive either a live donor or deceased donor kidney transplant

You may not qualify if…

• Not having FSGS

Where it is running

• Medstar Georgetown Transplant Institute — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.